Inventor · disambiguated record
Christopher Norbert Johnson
Also filed as: JOHNSON CHRISTOPHER N · JOHNSON CHRISTOPHER NORBERT
62 granted patents·26 pending applications·450 citations·filing 1990–2024
99Inventor score
Files withASTEX THERAPEUTICS LTD26SMITHKLINE BEECHAM PLC20GLAXO GROUP LTD16SMITHKLINE BEECHAM LTD7AHMED MAHMOOD1
Top patents by PatentIndex Score
88 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0295US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0395US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0494US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0593US11225476B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 18, 2022·3 cites·13 claims
- 0692US11866428B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2020·Granted Jan 9, 2024·2 cites·21 claims
- 0792US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0892US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0992US9617248B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 1092US7960563B2Indazoles used to treat estrogen receptor beta mediated disordersGLAXO GROUP LTD·Filed 2008·Granted Jun 14, 2011·33 cites·3 claims
- 1192US7601837B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2008·Granted Oct 13, 2009·15 cites·3 claims
- 1291US9980973B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted May 29, 2018·6 cites·21 claims
- 1391US9783538B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 10, 2017·12 cites·53 claims
- 1490US11643410B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2021·Granted May 9, 2023·1 cites·22 claims
- 1590US9676768B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2015·Granted Jun 13, 2017·8 cites·16 claims
- 1690US7799774B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2009·Granted Sep 21, 2010·11 cites·15 claims
- 1790US6677354B2Piperdines for use as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Jan 13, 2004·42 cites·18 claims
- 1889US7977337B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2010·Granted Jul 12, 2011·11 cites·10 claims
- 1989US7452888B2Quinoline derivatives and their use as 5-ht6 ligandsGLAXO GROUP LTD·Filed 2003·Granted Nov 18, 2008·23 cites·11 claims
- 2089US2025296930A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 2188US8236947B2Quinoline derivatives and their use as 5-HT6 ligandsAHMED MAHMOOD·Filed 2011·Granted Aug 7, 2012·11 cites·18 claims
- 2287US10618895B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2017·Granted Apr 14, 2020·4 cites·33 claims
- 2387US9018214B2Bicyclic heterocycle compounds and their uses in therapyWOOLFORD ALISON JO-ANNE·Filed 2012·Granted Apr 28, 2015·13 cites·21 claims
- 2486US9617283B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 2585US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 2685US2024199607A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2784US12202828B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2022·Granted Jan 21, 2025·0 cites·48 claims
- 2884US9663512B2Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2013·Granted May 30, 2017·8 cites·18 claims
- 2984US7943645B2Piperidine compounds for use as orexin receptor antagonistSMITHKLINE BEECHAM LTD·Filed 2008·Granted May 17, 2011·7 cites·8 claims
- 3083US12037345B2Heterobicyclic compounds for inhibiting the activity of SHP2TAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jul 16, 2024·2 cites·19 claims
- 3183US11466016B2Pharmaceutical compoundsOTSUKA PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·2 cites·27 claims
- 3283US6943160B2Morpholine derivatives as antagonists of orexin receptorsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Sep 13, 2005·18 cites·13 claims
- 3382US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 3480US6465485B1Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptorsSMITHKLINE BEECHAM PLC·Filed 2000·Granted Oct 15, 2002·14 cites·26 claims
- 3579US7166608B2N-aroyl piperazine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Jan 23, 2007·10 cites·3 claims
- 3678US7423052B2Piperidine compounds for use as orexin receptor antagoinstSMITHKLINE BEECHAM PLC·Filed 2002·Granted Sep 9, 2008·11 cites·15 claims
- 3777US7741329B2N-aroyl cyclic aminesSMITHKLINE BEECHAM LTD·Filed 2007·Granted Jun 22, 2010·2 cites·13 claims
- 3877US7439243B2Piperazinyl-quinoline derivatives useful for the treatment of CNS disordersGLAXO GROUP LTD·Filed 2004·Granted Oct 21, 2008·9 cites·12 claims
- 3977US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4074US7432270B2N-aroyl cyclic aminesSMITHKLINE BEECHAM PLC·Filed 2002·Granted Oct 7, 2008·6 cites·13 claims
- 4174US7365077B2Piperazine bis-amide derivatives and their use as antagonists of the orexin receptorSMITHKLINE BEECHAM PLC·Filed 2002·Granted Apr 29, 2008·8 cites·22 claims
- 4273US7893090B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Feb 22, 2011·1 cites·11 claims
- 4372US8222245B2Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)DEMONT EMMANUEL HUBERT·Filed 2008·Granted Jul 17, 2012·1 cites·5 claims
- 4471US8314147B2Benzamide derivatives as EP4 receptor agonistsGAIBA ALESSANDRA·Filed 2007·Granted Nov 20, 2012·2 cites·2 claims
- 4571US7470710B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Dec 30, 2008·4 cites·17 claims
- 4670US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 4768US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4867US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4967US2019375748A1Bicyclic heterocycle compounds and their uses in therapyASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 5063US7928125B2N-aroyl cyclic amine derivatives as orexin receptor antagonistsSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 19, 2011·0 cites·8 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →